Replies to post #10559 on Mast Therapeutics, Inc. (MSTX)

[jbem777]

Managements responsibility is not to release meaningless press releases to pump up the egos of shareholders. Everything they have stated they planned to do this year, they have, and have accompanied their achievements with press releases. Orphan status, trial completion, trial initiation, seeking partnerships, etc. So I am not sure what you think management should do.

All the previous "pumps" were related to their cancer related drugs that failed...like most do. Their runs were also catalyst related, not random pump and dumps like INO lately.

What's your break even price? PM is fine.

[The Silver Man]

I totally agree with you. I though the article was very good but in reality it means NOTHING. Good articles don't pay the bills or get my money back here.

Do you think you can get your $4 back?

[jape1]

the company now has a potent drug and a phase 3
the company must, calm investors, the company must
prepare a strategy to have on your side to small /
medium and large investors, the company has to say,
WE ARE HERE TO PROTECT AND MAINTAIN THE INVESTOR,
NOW WE HAVE POSSIBILITIES OF CHANGE AND LET'S MAKE